R&D

Meiji Seika Pharma Co., Ltd.

Meiji Seika Pharma is safeguarding lives with its research and development of new drugs and human vaccines. Our strengths in R&D also extend to generic drugs. Across multiple research centers and labs, we are working on creative solutions to some of the world's most critical health problems today.

Ethical Pharmaceuticals

We are researching and developing new pharmaceutical products. We are doing this with the aim of becoming the leading company in Japan in areas where we are strong by increasing the speed and improving the certainty of this research and development.

We are researching and developing generic pharmaceutical products. This is so that we can widely provide high-quality pharmaceutical products by taking advantage of the development capabilities and high quality we have cultivated up to now.

Research and Development Structure

  • a photo of a researcher conducting an experiment.

  • Pharmaceutical Research Center

    This center develops specification testing methods and manufacturing processes that enable the Meiji Group to strengthen and safeguard its supply of high-quality pharmaceuticals for the global market. The center's contribution to Chemistry, Manufacturing, and Controls (CMC) results in improvements in QA, product safety, and cost efficiency across a wide range of pharmaceutical products.

Open Innovation

The Meiji Group creates innovative technologies, products, and business models by investing in venture companies and collaborating with various organizations such as companies, research institutes, universities, and hospitals.

LEARN MORE

Ethical Consideration in R&D

As a leader in food and health, the Meiji Group conducts research activities in pursuit of new health value for consumers and patients. Meiji Group research and development is conducted in compliance with relevant laws, policies of the relevant ministries and agencies, and internal rules for product quality, efficacy and safety.

LEARN MORE